240 related articles for article (PubMed ID: 20103588)
1. Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia.
Nalbant D; Saleh M; Goldman FD; Widness JA; Veng-Pedersen P
J Pharmacol Exp Ther; 2010 May; 333(2):528-32. PubMed ID: 20103588
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablation.
Veng-Pedersen P; Chapel S; Al-Huniti NH; Schmidt RL; Sedars EM; Hohl RJ; Widness JA
Biopharm Drug Dispos; 2004 May; 25(4):149-56. PubMed ID: 15108217
[TBL] [Abstract][Full Text] [Related]
3. A differential pharmacokinetic analysis of the erythropoietin receptor population in newborn and adult sheep.
Veng-Pedersen P; Chapel S; Al-Huniti NH; Schmidt RL; Sedars EM; Hohl RJ; Widness JA
J Pharmacol Exp Ther; 2003 Aug; 306(2):532-7. PubMed ID: 12750427
[TBL] [Abstract][Full Text] [Related]
4. Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics.
Chapel SH; Veng-Pedersen P; Schmidt RL; Widness JA
Exp Hematol; 2001 Apr; 29(4):425-31. PubMed ID: 11301182
[TBL] [Abstract][Full Text] [Related]
5. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
Landau D; London L; Bandach I; Segev Y
PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemia.
Al-Huniti NH; Widness JA; Schmidt RL; Veng-Pedersen P
J Pharmacol Exp Ther; 2004 Jul; 310(1):202-8. PubMed ID: 14988424
[TBL] [Abstract][Full Text] [Related]
8. The erythropoietin receptor is not required for the development, function, and aging of rods and cells in the retinal periphery.
Caprara C; Britschgi C; Samardzija M; Grimm C
Mol Vis; 2014; 20():307-24. PubMed ID: 24644405
[TBL] [Abstract][Full Text] [Related]
9. Production and processing of erythropoietin receptor transcripts in brain.
Chin K; Yu X; Beleslin-Cokic B; Liu C; Shen K; Mohrenweiser HW; Noguchi CT
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):29-42. PubMed ID: 11000476
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.
Våtsveen TK; Sponaas AM; Tian E; Zhang Q; Misund K; Sundan A; Børset M; Waage A; Brede G
J Hematol Oncol; 2016 Aug; 9(1):75. PubMed ID: 27581518
[TBL] [Abstract][Full Text] [Related]
11. RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells.
Paragh G; Kumar SM; Rakosy Z; Choi SC; Xu X; Acs G
Am J Pathol; 2009 Apr; 174(4):1504-14. PubMed ID: 19264915
[TBL] [Abstract][Full Text] [Related]
12. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic analysis of stress erythropoiesis: change in erythropoietin receptor pool size following double phlebotomies in sheep.
Saleh MI; Widness JA; Veng-Pedersen P
Biopharm Drug Dispos; 2011 Apr; 32(3):131-9. PubMed ID: 21456051
[TBL] [Abstract][Full Text] [Related]
14. Functional conservation of erythropoietin signaling in zebrafish.
Paffett-Lugassy N; Hsia N; Fraenkel PG; Paw B; Leshinsky I; Barut B; Bahary N; Caro J; Handin R; Zon LI
Blood; 2007 Oct; 110(7):2718-26. PubMed ID: 17579187
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment.
Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C
Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708
[TBL] [Abstract][Full Text] [Related]
16. Binding of iodinated erythropoietin to rat bone marrow cells under normal and anemic conditions.
Akahane K; Tojo A; Fukamachi H; Kitamura T; Saito T; Urabe A; Takaku F
Exp Hematol; 1989 Feb; 17(2):177-82. PubMed ID: 2536329
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
Hamadmad SN; Hohl RJ
Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
[TBL] [Abstract][Full Text] [Related]
18. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.
Singh S; Dev A; Verma R; Pradeep A; Sathyanarayana P; Green JM; Narayanan A; Wojchowski DM
PLoS One; 2012; 7(7):e38530. PubMed ID: 22808010
[TBL] [Abstract][Full Text] [Related]
19. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
[TBL] [Abstract][Full Text] [Related]
20. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]